-
YTD
-2,72 %
-
1M
-8,85 %
-
3M
-5,1 %
-
6M
8,48 %
-
1Y
33,81 %
-
3Y
-
-
5Y
-
-
10Y
-
За ціною біржі з урахуванням виплат доходу
The ARK Genomic Revolution UCITS ETF is an actively managed ETF that seeks capital appreciation by investing in a portfolio comprised primarily of global companies involved in the gene therapy bio-informatics, bio-inspired computing, molecular medicine, and pharmaceutical innovations
The ARK Genomic Revolution UCITS ETF (USD) (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in Global. The ARK Investment fund’s base currency is USD and the share class was registered 12.04.2024 with unique ISIN - IE000O5M6XO1. Main exchange is London S.E. (USD) and ticker symbol is ARKG. The total expense ratio is 0.75%. The ARK Genomic Revolution UCITS ETF (USD) (Acc) pays dividends 0 time(s) per year.